Next Article in Journal
Comparative Nutrient Profiling of Retail Goat and Cow Milk
Next Article in Special Issue
The Metabolic Concept of Meal Sequence vs. Satiety: Glycemic and Oxidative Responses with Reference to Inflammation Risk, Protective Principles and Mediterranean Diet
Previous Article in Journal
Reduced Salivary Mucin Binding and Glycosylation in Older Adults Influences Taste in an In Vitro Cell Model
Previous Article in Special Issue
A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia
 
 
Article
Peer-Review Record

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

Nutrients 2019, 11(10), 2281; https://doi.org/10.3390/nu11102281
by Marco Pizzoferrato 1,2,*,†, Roberto de Sire 2,*,†, Fabio Ingravalle 2, Maria Chiara Mentella 3, Valentina Petito 1,2, Anna Maria Martone 4, Francesco Landi 4, Giacinto Abele Donato Miggiano 3, Maria Cristina Mele 3, Loris Riccardo Lopetuso 1,2, Elisa Schiavoni 1, Daniele Napolitano 1, Laura Turchini 1, Andrea Poscia 1, Nicola Nicolotti 5, Alfredo Papa 1, Alessandro Armuzzi 1, Franco Scaldaferri 1,2,*,‡ and Antonio Gasbarrini 1,2,‡
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Nutrients 2019, 11(10), 2281; https://doi.org/10.3390/nu11102281
Submission received: 30 August 2019 / Revised: 14 September 2019 / Accepted: 17 September 2019 / Published: 24 September 2019

Round 1

Reviewer 1 Report

Pizzoferrato and colleagues report the percentage of sarcopenia in an IBD cohort. I have only some minor suggestions

Minor points.

Table 1. Specify the biologics used for the treatment

Figure 1 The term prevalence is not appropriate, because this is a rather small population. Please state instead percentage.

How many patents with sarcopenia were treated with seroids?

Author Response

Dear Reviewer 1, 

thank you for your comments and suggestions.  We proceeded to make the requested changes

Reviewer 2 Report

Authors presented very elegant and interesting study, which is highlighting the fact, that IBD are systemic diseases.

I have one small remark - please rewrite the second part in the conclusions in abstract. Should be more clear.

Author Response

Dear Reviewer 2,

thank you for your comments and suggestions. We have rewrited the second part in the conclusions in abstract.

Back to TopTop